Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer

[Image: see text] Introduction: Early-activated RAS/RAF mutation status is a key molecular finding in colorectal cancer (CRC), while these mutations have been proposed as predictive and prognostic biomarkers. The present study has been designed as a longitudinal study to evaluate and summarize the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolatkhah, Roya, Dastgiri, Saeed, Eftekhar Sadat, Amir Taher, Farassati, Faris, Nezamdoust, Marzieh, Somi, Mohammad Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803924/
https://www.ncbi.nlm.nih.gov/pubmed/33469503
http://dx.doi.org/10.34172/bi.2021.02

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803924/
https://www.ncbi.nlm.nih.gov/pubmed/33469503
http://dx.doi.org/10.34172/bi.2021.02

Ejemplares similares